Status:
RECRUITING
Radiotherapy Delivery in Deep Inspiration for Pediatric Patients
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Aarhus University Hospital
Tampere University Hospital
Conditions:
Pediatric Cancer
Eligibility:
All Genders
5-17 years
Phase:
PHASE1
PHASE2
Brief Summary
TEDDI is a non-randomised phase II trial in Scandinavia. All pediatric patients, referred for radiotherapy in the thorax or abdomen and irrespective of diagnosis, are eligible. Deep inspiration breat...
Detailed Description
Background: The majority (approximately 80%) of pediatric patients with cancer become long-term survivors. Long-term follow-up of childhood cancer survivors has documented a substantial treatment-ind...
Eligibility Criteria
Inclusion
- Age 5-17 years.
- Patients with a tumor in the mediastinum or abdomen with possible need of radiotherapy according to current treatment guidelines, irrespective of cancer diagnosis.
- The ability to perform three sequential breath-holds of 20 seconds each during the coaching session.
- Written informed consent from parents or legal guardians.
Exclusion
- Age younger than 5 years or older than 17 years.
- The need for radiotherapy under general anesthesia.
- CNS tumor or pelvic localization.
- Unable to understand coaching information directly or through interpretation.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03315546
Start Date
January 1 2017
End Date
December 31 2029
Last Update
October 9 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical Oncology, Rigshospitalet
Copenhagen, Danmark, Denmark, 2100
2
Department of Clinical Oncology, Aarhus University Hospital
Aarhus, Denmark, 8000
3
Department of Radiation Oncology, Comprehensive Cancer Center, Helsinki University Hospital
Helsinki, Finland, 00290